First-line endocrine therapy for postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer: a systematic review and meta-analysis

por Shimoi, Tatsunori, Sagara, Yasuaki, Hara, Fumikata, Toyama, Tatsuya, Iwata, Hiroji
Publicado 2020

Clinical experience with nanoparticle albumin-bound paclitaxel, a novel taxane anticancer agent, and management of adverse events in females with breast cancer

por TAKASHIMA, SEIKI, KIYOTO, SACHIKO, TAKAHASHI, MINA, HARA, FUMIKATA, AOGI, KENJIRO, OHSUMI, SHOZO, MUKAI, RYOKO, FUJITA, YORIKO
Publicado 2015

Prospective observational study estimating willingness-to-pay for breast cancer treatments through contingent valuation method in Japanese breast cancer patients (JCOG1709A)

por Iwatani, Tsuguo, Hara, Fumikata, Shien, Tadahiko, Sasaki, Keita, Katayama, Hiroshi, Fukuda, Haruhiko, Shiroiwa, Takeru, Iwata, Hiroji
Publicado 2021

Anti-tumor effect of bisphosphonate (YM529) on non-small cell lung cancer cell lines

por Koshimune, Ryuichiro, Aoe, Motoi, Toyooka, Shinichi, Hara, Fumikata, Ouchida, Mamoru, Tokumo, Masaki, Sano, Yoshifumi, Date, Hiroshi, Shimizu, Nobuyoshi
Publicado 2007

Endometrial Metastasis from Breast Cancer during Adjuvant Endocrine Therapy

por Hara, Fumikata, Kiyoto, Sachiko, Takabatake, Daisuke, Takashima, Seiki, Aogi, Kenjiro, Ohsumi, Shozo, Teramoto, Norihiro, Nishimura, Rieko, Takashima, Shigemitsu
Publicado 2010

Metastatic Breast Cancer to the Stomach Resembling Early Gastric Cancer

por Hara, Fumikata, Kiyoto, Sachiko, Takabatake, Daisuke, Takashima, Seiki, Aogi, Kenjiro, Ohsumi, Shozo, Teramoto, Norihiro, Nishimura, Rieko, Takashima, Shigemitsu
Publicado 2010

The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the...

por Ikeda, Hirokuni, Taira, Naruto, Hara, Fumikata, Fujita, Takeo, Yamamoto, Hiromasa, Soh, Junichi, Toyooka, Shinichi, Nogami, Tomohiro, Shien, Tadahiko, Doihara, Hiroyoshi, Miyoshi, Shinichiro
Publicado 2010

The impact of obesity and endocrine therapy on the prognosis of premenopausal women with hormone receptor‐positive breast cancer: A single‐institute retrospective study

por Ozaki, Yukinori, Masuda, Jun, Kataoka, Akemi, Kogawa, Takahiro, Abe, Tomomi, Morizono, Hidetomo, Inagaki, Lina, Hara, Fumikata, Takano, Toshimi, Ueno, Takayuki, Ohno, Shinji
Publicado 2022

Correction: Factors associated with financial toxicity in patients with breast cancer in Japan: a comparison of patient and physician perspectives

por Saeki, Sumito, Iwatani, Tsuguo, Kitano, Atsuko, Sakurai, Naomi, Tanabe, Yuko, Yamauchi, Chikako, Igarashi, Ataru, Kajimoto, Yusuke, Kuba, Sayaka, Hara, Fumikata, Sagara, Yasuaki, Ohno, Shinji
Publicado 2023

Factors associated with financial toxicity in patients with breast cancer in Japan: a comparison of patient and physician perspectives

por Saeki, Sumito, Iwatani, Tsuguo, Kitano, Atsuko, Sakurai, Naomi, Tanabe, Yuko, Yamauchi, Chikako, Igarashi, Ataru, Kajimoto, Yusuke, Kuba, Sayaka, Hara, Fumikata, Sagara, Yasuaki, Ohno, Shinji
Publicado 2023

Patritumab plus trastuzumab and paclitaxel in human epidermal growth factor receptor 2‐overexpressing metastatic breast cancer

por Mukai, Hirofumi, Saeki, Toshiaki, Aogi, Kenjiro, Naito, Yoichi, Matsubara, Nobuaki, Shigekawa, Takashi, Ueda, Shigeto, Takashima, Seiki, Hara, Fumikata, Yamashita, Tomonari, Ohwada, Shoichi, Sasaki, Yasutsuna
Publicado 2016

Palbociclib in combination with fulvestrant in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-3 subgroup...

por Masuda, Norikazu, Inoue, Kenichi, Nakamura, Rikiya, Rai, Yoshiaki, Mukai, Hirofumi, Ohno, Shinji, Hara, Fumikata, Mori, Yuko, Hashigaki, Satoshi, Muramatsu, Yasuaki, Nagasawa, Takashi, Umeyama, Yoshiko, Huang, Xin, Iwata, Hiroji
Publicado 2018

Randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer

por Tsurutani, Junji, Hara, Fumikata, Kitada, Masahiro, Takahashi, Masato, Kikawa, Yuichiro, Kato, Hiroaki, Sakata, Eiko, Naito, Yoichi, Hasegawa, Yoshie, Saito, Tsuyoshi, Iwasa, Tsutomu, Taira, Naruto, Takashima, Tsutomu, Kashiwabara, Kosuke, Aihara, Tomohiko, Mukai, Hirofumi
Publicado 2020

Quality of life in a randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer

por Taira, Naruto, Kashiwabara, Kosuke, Tsurutani, Junji, Kitada, Masahiro, Takahashi, Masato, Kato, Hiroaki, Kikawa, Yuichiro, Sakata, Eiko, Naito, Yoichi, Hasegawa, Yoshie, Saito, Tsuyoshi, Iwasa, Tsutomu, Takashima, Tsutomu, Aihara, Tomohiko, Mukai, Hirofumi, Hara, Fumikata
Publicado 2021

Correction to: Quality of life in a randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer

por Taira, Naruto, Kashiwabara, Kosuke, Tsurutani, Junji, Kitada, Masahiro, Takahashi, Masato, Kato, Hiroaki, Kikawa, Yuichiro, Sakata, Eiko, Naito, Yoichi, Hasegawa, Yoshie, Saito, Tsuyoshi, Iwasa, Tsutomu, Takashima, Tsutomu, Aihara, Tomohiko, Mukai, Hirofumi, Hara, Fumikata
Publicado 2021

Clinicopathological predictors of postoperative upstaging to invasive ductal carcinoma (IDC) in patients preoperatively diagnosed with ductal carcinoma in situ (DCIS): a multi-inst...

por Tanaka, Kiyo, Masuda, Norikazu, Hayashi, Naoki, Sagara, Yasuaki, Hara, Fumikata, Kadoya, Takayuki, Matsui, Akira, Miyazaki, Chieko, Shien, Tadahiko, Tokunaga, Eriko, Hayashi, Takako, Niikura, Naoki, Maeda, Shigeto, Komoike, Yoshihumi, Bando, Hiroko, Kanbayashi, Chizuko, Iwata, Hiroji
Publicado 2021

Bi-weekly eribulin therapy for metastatic breast cancer: a multicenter phase II prospective study (JUST-STUDY)

por Ohtani, Shoichiro, Nakayama, Takahiro, Yoshinami, Tetsuhiro, Watanabe, Ken-ichi, Hara, Fumikata, Sagara, Yasuaki, Kawaguchi, Hidetoshi, Higaki, Kenji, Matsunami, Nobuki, Hasegawa, Yoshie, Takahashi, Masato, Mizutani, Makiko, Morimoto, Takashi, Sato, Masako, Itoh, Mitsuya, Morita, Satoshi, Masuda, Norikazu
Publicado 2018

Serial circulating tumor DNA monitoring of CDK4/6 inhibitors response in metastatic breast cancer

por Chin, Yoon Ming, Shibayama, Tomoko, Chan, Hiu Ting, Otaki, Masumi, Hara, Fumikata, Kobayashi, Takayuki, Kobayashi, Kokoro, Hosonaga, Mari, Fukada, Ippei, Inagaki, Lina, Ono, Makiko, Ito, Yoshinori, Takahashi, Shunji, Ohno, Shinji, Ueno, Takayuki, Nakamura, Yusuke, Low, Siew‐Kee
Publicado 2022

Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2: a retrospective si...

por Ozaki, Yukinori, Aoyama, Yosuke, Masuda, Jun, Inagaki, Lina, Kawai, Saori, Shibayama, Tomoko, Maeda, Tetsuyo, Kurata, Mami, Yoshida, Kazuyo, Saeki, Sumito, Hosonaga, Mari, Fukada, Ippei, Hara, Fumikata, Kobayashi, Takayuki, Kobayashi, Kokoro, Miyake, Satoshi, Takano, Toshimi, Ueno, Takayuki, Ohno, Shinji
Publicado 2022

Mitigation of paclitaxel-induced peripheral neuropathy in breast cancer patients using limb-cooling apparatus: a study protocol for a randomized controlled trial

por Funasaka, Chikako, Hanai, Akiko, Zenda, Sadamoto, Mori, Keita, Fukui, Makoto, Hirano, Nami, Shinohara, Rie, Fuse, Nozomu, Wakabayashi, Masashi, Itagaki, Mai, Tomioka, Yutaka, Nishina, Michihiko, Arai, Yasuaki, Kogawa, Takahiro, Ozaki, Yukinori, Nishimura, Meiko, Kobayashi, Takayuki, Hara, Fumikata, Takano, Toshimi, Mukohara, Toru
Publicado 2023